Pilot Trial of Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Hormone-Refractory Prostate Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fludarabine (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 01 Jun 2012 Biomarkers information updated
- 17 Nov 2009 Actual end date (Mar 2008) and actual number of patients (0) added as reported by ClinicalTrials.gov.
- 17 Nov 2009 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.